Ramipril and Hyperthyroid - a phase IV clinical study of FDA data

Summary:

Hyperthyroid is reported as a side effect among people who take Ramipril (ramipril), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Amlodipine, and have Pain.

The phase IV clinical study analyzes which people have Hyperthyroid when taking Ramipril. It is created by eHealthMe based on reports of 144,209 people who have side effects when taking Ramipril from the FDA, and is updated regularly.

What is Ramipril?

Ramipril has active ingredients of ramipril. It is often used in high blood pressure. eHealthMe is studying from 147,380 Ramipril users. Check the latest studies of Ramipril.

What is Hyperthyroid?

Hyperthyroid is found to be associated with 1,145 drugs and 1,397 conditions by eHealthMe. Check the latest studies of Hyperthyroid.

On Sep, 10, 2025

144,209 people reported to have side effects when taking Ramipril.
Among them, 462 people (0.32%) have Hyperthyroid.

Among these 462 people:

How long have people been on Ramipril when they have Hyperthyroid? *

What is the gender of people who have Hyperthyroid when taking Ramipril? *

female: 42.18 %
male: 57.82 %

What is the age of people who have Hyperthyroid when taking Ramipril? *

What are other drugs people take besides Ramipril? *

What are other side effects people have besides Hyperthyroid? *

Diarrhea: 123 people, 26.62%
Nausea (feeling of having an urge to vomit): 97 people, 21.00%
Erythema Multiforme (a type of hypersensitivity reaction): 86 people, 18.61%
Rashes (redness): 81 people, 17.53%
Respiratory Disorder (respiratory disease): 71 people, 15.37%
Electrolyte Imbalance: 70 people, 15.15%
Agitation (state of anxiety or nervous excitement): 68 people, 14.72%
Cholecystitis (infection of gallbladder): 68 people, 14.72%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 67 people, 14.50%
Gallstones (stone formation by bile component): 67 people, 14.50%

What are the existing conditions these people have? *

Pain: 91 people, 19.70%
Hyperlipidaemia (presence of excess lipids in the blood): 88 people, 19.05%
Diabetes: 78 people, 16.88%
Fever: 77 people, 16.67%
Dyspnea (difficult or laboured breathing): 77 people, 16.67%
Nausea (feeling of having an urge to vomit): 73 people, 15.80%
Diarrhea: 73 people, 15.80%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 73 people, 15.80%
Agitation (state of anxiety or nervous excitement): 72 people, 15.58%
Cholecystitis (infection of gallbladder): 67 people, 14.50%

* Approximation only. Some reports may have incomplete information.

Do you take Ramipril and have Hyperthyroid?

- Check whether Hyperthyroid is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ramipril:

Ramipril (147,380 reports)

Hyperthyroid treatments and more:

Hyperthyroid (26,827 reports)

Common Ramipril side effects:

Browse all side effects of Ramipril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common drugs associated with Hyperthyroid:

Browse all the drugs that are associated with Hyperthyroid:

Hyperthyroid (1,145 drugs)

Common conditions associated with Hyperthyroid:

Browse all the conditions that are associated with Hyperthyroid:

Hyperthyroid (1,397 conditions)

Drugs similar to Ramipril and Hyperthyroid :

How the study uses the data?

The study uses data from the FDA. It is based on ramipril (the active ingredients of Ramipril) and Ramipril (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.